bioAffinity Technologies, Inc. (BIAF) Q4 2024 Annual Earnings

BIAF·Reported March 31, 2025·Before market open

bioAffinity Technologies, Inc. reported Q4 2024 revenue of $2.2M, missed analyst consensus of $2.4M by $210.0K. Diluted EPS came in at $-0.21, missed the $-0.14 consensus by $0.07.

Revenue

$2.2Mmissed by $210.0K

Consensus: $2.4M

Diluted EPS

$-0.21missed by $0.07

Consensus: $-0.14

SEC Filings

Earnings release8-K not filed yet

Annual report10-K · 0001641172-25-001840

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q4 2024 Earnings FAQ

Common questions about bioAffinity Technologies, Inc.'s Q4 2024 earnings report.

bioAffinity Technologies, Inc. (BIAF) reported Q4 2024 earnings on March 31, 2025 before market open.

bioAffinity Technologies, Inc. reported revenue of $2.2M and diluted EPS of $-0.21 for Q4 2024.

Revenue missed the consensus estimate of $2.4M by $210.0K. EPS missed the consensus estimate of $-0.14 by $0.07.

You can read the 10-K periodic report (0001641172-25-001840) directly on SEC EDGAR. The filing index links above go to sec.gov.